vimarsana.com

Latest Breaking News On - Allergan aesthetics - Page 13 : vimarsana.com

AbbVie Expands Biologics Manufacturing Capacity with a $223 Million Investment in Singapore Manufacturing Site

AbbVie (NYSE: ABBV) strengthened its manufacturing capabilities by breaking ground Thursday on a new US$223 million (S$301 million) expansion of its Singapore manufacturing facility. This new investment will add more than 100 jobs and new biologics manufacturing capacity to AbbVie's global network.

Allergan to Discuss Diverse Clinical Skin Care Research for Breakthrough Products

Goberdhan s presentation will address how the understanding of dermatological issues impacting underrepresented or underserved groups can lead to better product innovation.

Allergan Aesthetics Showcases Commitment to Individuality, Innovation, and Integrity at IMCAS World Congress 2024

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.